thiazoles has been researched along with treosulfan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erlacher, M; Hilger, RA; Khanna, C; Konanz, C; Kontny, U; Lissat, A; Mendoza, A; Niemeyer, CM; Reichardt, W; Uhl, M; Werner, S | 1 |
| Esser, R; Kalaäoui, RE; Klingebiel, T; Kloess, S; Koehl, U; Kreuter, J; Lehrnbecher, T; Munkelt, D; Schubert, R; Schwabe, D; Wehner, S; Zimmermann, SY | 1 |
2 other study(ies) available for thiazoles and treosulfan
| Article | Year |
|---|---|
Preclinical studies of treosulfan demonstrate potent activity in Ewing's sarcoma.
Topics: Animals; Annexin A5; Antineoplastic Agents, Alkylating; Apoptosis; Bisbenzimidazole; Blotting, Western; Busulfan; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Coloring Agents; G1 Phase; Indicators and Reagents; Injections, Intraperitoneal; Mice; Mice, Nude; Sarcoma, Ewing; Tetrazolium Salts; Thiazoles; Xenograft Model Antitumor Assays | 2008 |
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Apoptosis; Busulfan; Caspase 3; Cell Line, Tumor; Child; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia; Stem Cells; T-Lymphocytes; Tetrazolium Salts; Thiazoles; Vidarabine | 2008 |